Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea

Summary

This is a randomized, 3-period, placebo-controlled, crossover study to examine the efficacy and safety of AD182 and AD504 versus placebo in patients with obstructive sleep apnea.

Timeline

Start

2020-12-01

Primary completion

2021-09-01

Completion

2021-09-01

Publications

• Corser B, Eves E, Warren-McCormick J, Rucosky G. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway. J Clin Sleep Med. 2023 Jun 1;19(6):1035-1042. doi: 10.5664/jcsm.10464.

Drugs

Indications